239 related articles for article (PubMed ID: 18577998)
1. Drug insight: aggrecanases as therapeutic targets for osteoarthritis.
Fosang AJ; Little CB
Nat Clin Pract Rheumatol; 2008 Aug; 4(8):420-7. PubMed ID: 18577998
[TBL] [Abstract][Full Text] [Related]
2. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
Huang K; Wu LD
J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
[TBL] [Abstract][Full Text] [Related]
3. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
Troeberg L; Fushimi K; Khokha R; Emonard H; Ghosh P; Nagase H
FASEB J; 2008 Oct; 22(10):3515-24. PubMed ID: 18632849
[TBL] [Abstract][Full Text] [Related]
4. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.
Verma P; Dalal K
J Cell Biochem; 2011 Dec; 112(12):3507-14. PubMed ID: 21815191
[TBL] [Abstract][Full Text] [Related]
5. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review.
Bondeson J; Wainwright S; Hughes C; Caterson B
Clin Exp Rheumatol; 2008; 26(1):139-45. PubMed ID: 18328163
[TBL] [Abstract][Full Text] [Related]
6. [Research progress of a disintegrin and metalloproteinase with thrombospondin motif 4 and 5 in osteoarthritis].
Ji Q; Zhang Q; Wang Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Sep; 27(9):1080-4. PubMed ID: 24279019
[TBL] [Abstract][Full Text] [Related]
7. Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.
Durham TB; Klimkowski VJ; Rito CJ; Marimuthu J; Toth JL; Liu C; Durbin JD; Stout SL; Adams L; Swearingen C; Lin C; Chambers MG; Thirunavukkarasu K; Wiley MR
J Med Chem; 2014 Dec; 57(24):10476-85. PubMed ID: 25415648
[TBL] [Abstract][Full Text] [Related]
8. Aggrecanases in the human synovial fluid at different stages of osteoarthritis.
Zhang E; Yan X; Zhang M; Chang X; Bai Z; He Y; Yuan Z
Clin Rheumatol; 2013 Jun; 32(6):797-803. PubMed ID: 23370724
[TBL] [Abstract][Full Text] [Related]
9. [Aggrecanases and osteoarthritis].
Li C; Cao YP; Guan ZP; Huang de Y; Ge ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):611-2. PubMed ID: 19829688
[TBL] [Abstract][Full Text] [Related]
10. Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes.
Takizawa M; Yatabe T; Okada A; Chijiiwa M; Mochizuki S; Ghosh P; Okada Y
FEBS Lett; 2008 Aug; 582(19):2945-9. PubMed ID: 18671975
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin, a citrus polymethoxy flavonoid, suppresses gene expression and production of aggrecanases-1 and -2 in collagen-induced arthritic mice.
Imada K; Lin N; Liu C; Lu A; Chen W; Yano M; Sato T; Ito A
Biochem Biophys Res Commun; 2008 Aug; 373(2):181-5. PubMed ID: 18541144
[TBL] [Abstract][Full Text] [Related]
12. The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.
Moncada-Pazos A; Obaya AJ; Viloria CG; López-Otín C; Cal S
J Mol Med (Berl); 2011 Jun; 89(6):611-9. PubMed ID: 21365186
[TBL] [Abstract][Full Text] [Related]
13. Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition.
Cuffaro D; Ciccone L; Rossello A; Nuti E; Santamaria S
J Med Chem; 2022 Oct; 65(20):13505-13532. PubMed ID: 36250680
[TBL] [Abstract][Full Text] [Related]
14. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
15. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
Nuti E; Santamaria S; Casalini F; Yamamoto K; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Marini AM; Salerno S; Taliani S; Da Settimo F; Nagase H; Rossello A
Eur J Med Chem; 2013 Apr; 62():379-94. PubMed ID: 23376997
[TBL] [Abstract][Full Text] [Related]
16. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.
Boeuf S; Graf F; Fischer J; Moradi B; Little CB; Richter W
Eur Cell Mater; 2012 May; 23():320-32. PubMed ID: 22562232
[TBL] [Abstract][Full Text] [Related]
18. The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinic.
Malfait AM; Tortorella MD
Clin Exp Rheumatol; 2019; 37 Suppl 120(5):130-134. PubMed ID: 31621572
[TBL] [Abstract][Full Text] [Related]
19. 5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5.
Gilbert AM; Bursavich MG; Lombardi S; Georgiadis KE; Reifenberg E; Flannery CR; Morris EA
Bioorg Med Chem Lett; 2007 Mar; 17(5):1189-92. PubMed ID: 17210252
[TBL] [Abstract][Full Text] [Related]
20. Development of human neutralizing antibody to ADAMTS4 (aggrecanase-1) and ADAMTS5 (aggrecanase-2).
Shiraishi A; Mochizuki S; Miyakoshi A; Kojoh K; Okada Y
Biochem Biophys Res Commun; 2016 Jan; 469(1):62-69. PubMed ID: 26612259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
